Watson cognitive tech will be integrated into the MAP Recovery Network Platform to enhance the platform's existing capabilities.
Initially, IBM Watson Health's Imaging group will distribute the MedyMatch brain bleed detection app globally through its vendor neutral sales channels.
Together with Big Blue, the charity aims to provide people seeking help with access to personalized information from the Arthritis Research UK website.
The company has also launched Watson Health Consulting Services unit to help clients transform healthcare by leveraging the power of cognitive solutions.
The two parties will explore the exchange of data from several sources, such as EMRs, clinical trials, genomic data, and health data from mobile devices.
This AI app could be focused in the area of healthcare, but could also be aimed at education, energy, environment, global development or exploration.
The initiative is comprised of more than 15 leading health systems, academic medical centers, ambulatory radiology providers and imaging technology companies.
The app will help surgeons streamline their workflow by delivering patient information and clinical insights, as well as intraocular lens (IOL) options.
The two parties will develop an experimental IoT system that uses connected devices to enable remote measurement of health and quality of life in real-time.
The Big Blue has also introduced Watson Health for ResearchKit, which is available at no charge to qualified, non-profit health researchers.